Overview

Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population

Status:
Completed
Trial end date:
2004-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study safety and efficacy of omeprazole standard treatment in a Japanese non-erosive reflux disease population.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Collaborator:
Mitsubishi Tanabe Pharma Corporation
Treatments:
Omeprazole